2cureX AB (publ) (FRA:2QE)

Market Cap	4.10M -12.3%
Revenue (ttm)	174.00K -49.7%
Net Income	-2.32M
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (4.79%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Open	0.1560
Previous Close	0.1626
Day's Range	0.1560 - 0.1560
52-Week Range	0.0432 - 0.4910
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 21, 2026

About 2cureX AB

2cureX AB (publ) operates as a medical technology company in Europe. Its proprietary IndiTreat test family creates various 3D tumor replicas—called tumoroids—from a patient’s biopsy to identify which chemotherapy or targeted drugs that are effective for that specific tumor. 2cureX AB (publ) was incorporated in 2006 and is based in Landskrona, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2QE

Financial Performance

In 2023, 2cureX AB's revenue was 2.95 million, a decrease of -12.53% compared to the previous year's 3.37 million. Losses were -32.52 million, 9.23% more than in 2022.

Financial numbers in SEK